Marathon Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Buy |
2,576
+450
| +21% | +$351K | 0.51% | 49 |
|
2025
Q1 | $1.76M | Sell |
2,126
-180
| -8% | -$149K | 0.47% | 50 |
|
2024
Q4 | $1.78M | Sell |
2,306
-69
| -3% | -$53.3K | 0.44% | 48 |
|
2024
Q3 | $2.1M | Sell |
2,375
-55
| -2% | -$48.7K | 0.51% | 49 |
|
2024
Q2 | $2.2M | Hold |
2,430
| – | – | 0.56% | 45 |
|
2024
Q1 | $1.89M | Sell |
2,430
-130
| -5% | -$101K | 0.45% | 52 |
|
2023
Q4 | $1.49M | Sell |
2,560
-30
| -1% | -$17.5K | 0.38% | 62 |
|
2023
Q3 | $1.39M | Hold |
2,590
| – | – | 0.35% | 62 |
|
2023
Q2 | $1.21M | Sell |
2,590
-106
| -4% | -$49.7K | 0.3% | 66 |
|
2023
Q1 | $926K | Hold |
2,696
| – | – | 0.23% | 73 |
|
2022
Q4 | $986K | Sell |
2,696
-41
| -1% | -$15K | 0.27% | 64 |
|
2022
Q3 | $885K | Hold |
2,737
| – | – | 0.25% | 72 |
|
2022
Q2 | $887K | Buy |
+2,737
| New | +$887K | 0.29% | 65 |
|
2022
Q1 | – | Sell |
-2,737
| Closed | -$756K | – | 131 |
|
2021
Q4 | $756K | Sell |
2,737
-951
| -26% | -$263K | 0.18% | 81 |
|
2021
Q3 | $853K | Buy |
3,688
+961
| +35% | +$222K | 0.19% | 73 |
|
2021
Q2 | $625K | Sell |
2,727
-100
| -4% | -$22.9K | 0.14% | 84 |
|
2021
Q1 | $528K | Hold |
2,827
| – | – | 0.14% | 88 |
|
2020
Q4 | $477K | Buy |
2,827
+30
| +1% | +$5.06K | 0.14% | 84 |
|
2020
Q3 | $414K | Sell |
2,797
-103
| -4% | -$15.2K | 0.15% | 83 |
|
2020
Q2 | $476K | Hold |
2,900
| – | – | 0.18% | 68 |
|
2020
Q1 | $402K | Hold |
2,900
| – | – | 0.18% | 66 |
|
2019
Q4 | $381K | Buy |
+2,900
| New | +$381K | 0.13% | 95 |
|